Australian Neuro-muscular Research Institute and Centre for Neuromuscular and Neurological disorders, University of Western Australia, Queen Elizabeth II Medical Centre, Perth, WA, Australia.
J Neuroimmunol. 2012 Aug 15;249(1-2):66-70. doi: 10.1016/j.jneuroim.2012.04.007. Epub 2012 May 2.
The frequency of myositis-associated and myositis-specific autoantibodies (AAb) was compared in 51 s-IBM patients and a population control group. Non-organ specific AAb (ANA, anti-Ro52, anti-Ro60, anti-La, anti-RNP) but not anti-thyroid peroxidase, anti-tissue transglutaminase or myositis-specific antibodies, were more frequent in s-IBM patients, and 14/51 (27%) had another autoimmune disease (Sjögren's syndrome, thyroiditis, psoriasis, vitiligo). The presence of AAb did not correlate with carriage of HLA-DRB10301, but there was a negative correlation between ANA/anti-Ro52 and carriage of HLA-DRB11301. The findings in this cohort confirm that patients with sIBM do not show evidence of a muscle-specific humoral immune process but have an increased frequency of non-organ specific AAb and other autoimmune disorders.
在 51 名 s-IBM 患者和一个人群对照组中,比较了肌炎相关自身抗体 (AAb) 和肌炎特异性自身抗体 (AAb) 的频率。非器官特异性 AAb(ANA、抗 Ro52、抗 Ro60、抗 La、抗 RNP)而非抗甲状腺过氧化物酶、抗组织转谷氨酰胺酶或肌炎特异性抗体在 s-IBM 患者中更为常见,且 14/51(27%)患有另一种自身免疫性疾病(干燥综合征、甲状腺炎、银屑病、白癜风)。AAb 的存在与 HLA-DRB10301 无关,但 ANA/抗 Ro52 与 HLA-DRB11301 的携带呈负相关。本队列研究的结果证实,sIBM 患者并未表现出肌肉特异性体液免疫过程的证据,但具有非器官特异性 AAb 和其他自身免疫性疾病的更高频率。